Information Technology Services
Compare Stocks
5 / 10Stock Comparison
VRRM vs PRSO vs CWAN vs REZI vs OSIS
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Software - Application
Security & Protection Services
Hardware, Equipment & Parts
VRRM vs PRSO vs CWAN vs REZI vs OSIS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Information Technology Services | Semiconductors | Software - Application | Security & Protection Services | Hardware, Equipment & Parts |
| Market Cap | $2.22B | $7M | $7.21B | $6.04B | $3.97B |
| Revenue (TTM) | $979M | $13M | $826M | $7.47B | $1.81B |
| Net Income (TTM) | $131M | $-5M | $-48M | $-527M | $152M |
| Gross Margin | 97.5% | 58.8% | 66.0% | 29.4% | 32.8% |
| Operating Margin | 23.8% | -39.3% | 1.4% | 8.1% | 12.1% |
| Forward P/E | 10.8x | — | 34.6x | 13.1x | 23.0x |
| Total Debt | $38M | $321K | $883M | $3.17B | $682M |
| Cash & Equiv. | $65M | $3M | $91M | $661M | $106M |
VRRM vs PRSO vs CWAN vs REZI vs OSIS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| Verra Mobility Corp… (VRRM) | 100 | 97.1 | -2.9% |
| Peraso Inc. (PRSO) | 100 | 0.5 | -99.5% |
| Clearwater Analytic… (CWAN) | 100 | 94.8 | -5.2% |
| Resideo Technologie… (REZI) | 100 | 162.4 | +62.4% |
| OSI Systems, Inc. (OSIS) | 100 | 254.3 | +154.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VRRM vs PRSO vs CWAN vs REZI vs OSIS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VRRM carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.60
- Rev growth 11.4%, EPS growth 347.4%, 3Y rev CAGR 9.7%
- Lower volatility, beta 0.60, Low D/E 13.0%, current ratio 2.09x
- Beta 0.60, current ratio 2.09x
PRSO lags the leaders in this set but could rank higher in a more targeted comparison.
CWAN ranks third and is worth considering specifically for growth.
- 61.9% revenue growth vs PRSO's 6.0%
REZI is the #2 pick in this set and the best alternative if dividends and momentum is your priority.
- 0.6% yield; 2-year raise streak; the other 4 pay no meaningful dividend
- +111.6% vs VRRM's -34.1%
OSIS is the clearest fit if your priority is long-term compounding.
- 372.9% 10Y total return vs VRRM's 46.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 61.9% revenue growth vs PRSO's 6.0% | |
| Value | Lower P/E (10.8x vs 23.0x) | |
| Quality / Margins | 13.4% margin vs PRSO's -39.0% | |
| Stability / Safety | Beta 0.60 vs REZI's 2.27, lower leverage | |
| Dividends | 0.6% yield; 2-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +111.6% vs VRRM's -34.1% | |
| Efficiency (ROA) | 7.7% ROA vs PRSO's -78.9%, ROIC 23.5% vs -5.1% |
VRRM vs PRSO vs CWAN vs REZI vs OSIS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
VRRM vs PRSO vs CWAN vs REZI vs OSIS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
VRRM leads in 3 of 6 categories
REZI leads 1 • PRSO leads 0 • CWAN leads 0 • OSIS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
VRRM leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
REZI is the larger business by revenue, generating $7.5B annually — 574.7x PRSO's $13M. VRRM is the more profitable business, keeping 13.4% of every revenue dollar as net income compared to PRSO's -39.0%. On growth, CWAN holds the edge at +74.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $979M | $13M | $826M | $7.5B | $1.8B |
| EBITDAEarnings before interest/tax | $351M | -$5M | $94M | $802M | $229M |
| Net IncomeAfter-tax profit | $131M | -$5M | -$48M | -$527M | $152M |
| Free Cash FlowCash after capex | $104M | -$5M | $152M | -$1.3B | $77M |
| Gross MarginGross profit ÷ Revenue | +97.5% | +58.8% | +66.0% | +29.4% | +32.8% |
| Operating MarginEBIT ÷ Revenue | +23.8% | -39.3% | +1.4% | +8.1% | +12.1% |
| Net MarginNet income ÷ Revenue | +13.4% | -39.0% | -5.8% | -7.1% | +8.4% |
| FCF MarginFCF ÷ Revenue | +10.7% | -40.9% | +18.5% | -16.8% | +4.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +0.1% | -15.8% | +74.4% | +2.0% | +2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -15.0% | +82.7% | -137.9% | +11.4% | -3.8% |
Valuation Metrics
VRRM leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 17.2x trailing earnings, VRRM trades at a 38% valuation discount to OSIS's 27.7x P/E. On an enterprise value basis, VRRM's 6.2x EV/EBITDA is more attractive than CWAN's 70.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.2B | $7M | $7.2B | $6.0B | $4.0B |
| Enterprise ValueMkt cap + debt − cash | $2.2B | $4M | $8.0B | $8.5B | $4.6B |
| Trailing P/EPrice ÷ TTM EPS | 17.21x | -0.26x | -173.50x | -10.68x | 27.68x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.82x | — | 34.60x | 13.07x | 23.05x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 1.67x |
| EV / EBITDAEnterprise value multiple | 6.19x | — | 70.39x | 10.65x | 17.43x |
| Price / SalesMarket cap ÷ Revenue | 2.27x | 0.49x | 9.85x | 0.81x | 2.32x |
| Price / BookPrice ÷ Book value/share | 8.05x | 0.82x | 3.24x | 2.06x | 4.35x |
| Price / FCFMarket cap ÷ FCF | 16.26x | — | 43.85x | — | 70.85x |
Profitability & Efficiency
VRRM leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
VRRM delivers a 39.7% return on equity — every $100 of shareholder capital generates $40 in annual profit, vs $-149 for PRSO. PRSO carries lower financial leverage with a 0.09x debt-to-equity ratio, signaling a more conservative balance sheet compared to REZI's 1.09x. On the Piotroski fundamental quality scale (0–9), VRRM scores 8/9 vs CWAN's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +39.7% | -148.6% | -2.4% | -18.1% | +16.7% |
| ROA (TTM)Return on assets | +7.7% | -78.9% | -1.6% | -6.2% | +6.3% |
| ROICReturn on invested capital | +23.5% | -5.1% | +1.1% | +9.0% | +11.5% |
| ROCEReturn on capital employed | +16.7% | -2.5% | +1.4% | +9.3% | +16.3% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 5 | 2 | 4 | 4 |
| Debt / EquityFinancial leverage | 0.13x | 0.09x | 0.43x | 1.09x | 0.72x |
| Net DebtTotal debt minus cash | -$27M | -$3M | $792M | $2.5B | $576M |
| Cash & Equiv.Liquid assets | $65M | $3M | $91M | $661M | $106M |
| Total DebtShort + long-term debt | $38M | $321,000 | $883M | $3.2B | $682M |
| Interest CoverageEBIT ÷ Interest expense | 3.13x | -1243.50x | 0.07x | -2.36x | 11.43x |
Total Returns (Dividends Reinvested)
REZI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in OSIS five years ago would be worth $24,991 today (with dividends reinvested), compared to $72 for PRSO. Over the past 12 months, REZI leads with a +111.6% total return vs VRRM's -34.1%. The 3-year compound annual growth rate (CAGR) favors REZI at 34.9% vs PRSO's -60.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -34.5% | +4.7% | +0.7% | +14.5% | -5.7% |
| 1-Year ReturnPast 12 months | -34.1% | +6.0% | +6.1% | +111.6% | +8.9% |
| 3-Year ReturnCumulative with dividends | -15.8% | -93.8% | +65.7% | +145.5% | +103.9% |
| 5-Year ReturnCumulative with dividends | +0.8% | -99.3% | -4.3% | +33.0% | +149.9% |
| 10-Year ReturnCumulative with dividends | +46.3% | -100.0% | -4.3% | +38.9% | +372.9% |
| CAGR (3Y)Annualised 3-year return | -5.6% | -60.4% | +18.3% | +34.9% | +26.8% |
Risk & Volatility
Evenly matched — VRRM and CWAN each lead in 1 of 2 comparable metrics.
Risk & Volatility
VRRM is the less volatile stock with a 0.60 beta — it tends to amplify market swings less than REZI's 2.27 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CWAN currently trades 96.9% from its 52-week high vs PRSO's 39.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.60x | 1.11x | 0.80x | 2.27x | 1.44x |
| 52-Week HighHighest price in past year | $25.83 | $2.37 | $25.07 | $45.29 | $311.27 |
| 52-Week LowLowest price in past year | $13.02 | $0.77 | $15.74 | $18.88 | $204.00 |
| % of 52W HighCurrent price vs 52-week peak | +56.6% | +39.7% | +96.9% | +88.9% | +77.5% |
| RSI (14)Momentum oscillator 0–100 | 36.1 | 46.6 | 69.9 | 61.4 | 30.1 |
| Avg Volume (50D)Average daily shares traded | 1.6M | 9.1M | 4.0M | 1.1M | 285K |
Analyst Outlook
Evenly matched — VRRM and REZI each lead in 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: VRRM as "Buy", CWAN as "Hold", REZI as "Buy", OSIS as "Buy". Consensus price targets imply 64.0% upside for VRRM (target: $24) vs -0.7% for REZI (target: $40). REZI is the only dividend payer here at 0.58% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $24.00 | — | $24.96 | $40.00 | $293.50 |
| # AnalystsCovering analysts | 11 | — | 13 | 7 | 17 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +0.6% | — |
| Dividend StreakConsecutive years of raises | 2 | — | 1 | 2 | — |
| Dividend / ShareAnnual DPS | — | — | — | $0.23 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.3% | 0.0% | +2.0% |
VRRM leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). REZI leads in 1 (Total Returns). 2 tied.
VRRM vs PRSO vs CWAN vs REZI vs OSIS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VRRM or PRSO or CWAN or REZI or OSIS a better buy right now?
For growth investors, Clearwater Analytics Holdings, Inc.
(CWAN) is the stronger pick with 61. 9% revenue growth year-over-year, versus 6. 0% for Peraso Inc. (PRSO). Verra Mobility Corporation (VRRM) offers the better valuation at 17. 2x trailing P/E (10. 8x forward), making it the more compelling value choice. Analysts rate Verra Mobility Corporation (VRRM) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VRRM or PRSO or CWAN or REZI or OSIS?
On trailing P/E, Verra Mobility Corporation (VRRM) is the cheapest at 17.
2x versus OSI Systems, Inc. at 27. 7x. On forward P/E, Verra Mobility Corporation is actually cheaper at 10. 8x.
03Which is the better long-term investment — VRRM or PRSO or CWAN or REZI or OSIS?
Over the past 5 years, OSI Systems, Inc.
(OSIS) delivered a total return of +149. 9%, compared to -99. 3% for Peraso Inc. (PRSO). Over 10 years, the gap is even starker: OSIS returned +372. 9% versus PRSO's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VRRM or PRSO or CWAN or REZI or OSIS?
By beta (market sensitivity over 5 years), Verra Mobility Corporation (VRRM) is the lower-risk stock at 0.
60β versus Resideo Technologies, Inc. 's 2. 27β — meaning REZI is approximately 279% more volatile than VRRM relative to the S&P 500. On balance sheet safety, Peraso Inc. (PRSO) carries a lower debt/equity ratio of 9% versus 109% for Resideo Technologies, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VRRM or PRSO or CWAN or REZI or OSIS?
By revenue growth (latest reported year), Clearwater Analytics Holdings, Inc.
(CWAN) is pulling ahead at 61. 9% versus 6. 0% for Peraso Inc. (PRSO). On earnings-per-share growth, the picture is similar: Verra Mobility Corporation grew EPS 347. 4% year-over-year, compared to -718. 0% for Resideo Technologies, Inc.. Over a 3-year CAGR, PRSO leads at 36. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VRRM or PRSO or CWAN or REZI or OSIS?
Verra Mobility Corporation (VRRM) is the more profitable company, earning 14.
0% net margin versus -73. 6% for Peraso Inc. — meaning it keeps 14. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VRRM leads at 24. 4% versus -85. 3% for PRSO. At the gross margin level — before operating expenses — VRRM leads at 96. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VRRM or PRSO or CWAN or REZI or OSIS more undervalued right now?
On forward earnings alone, Verra Mobility Corporation (VRRM) trades at 10.
8x forward P/E versus 34. 6x for Clearwater Analytics Holdings, Inc. — 23. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VRRM: 64. 0% to $24. 00.
08Which pays a better dividend — VRRM or PRSO or CWAN or REZI or OSIS?
In this comparison, REZI (0.
6% yield) pays a dividend. VRRM, PRSO, CWAN, OSIS do not pay a meaningful dividend and should not be held primarily for income.
09Is VRRM or PRSO or CWAN or REZI or OSIS better for a retirement portfolio?
For long-horizon retirement investors, Verra Mobility Corporation (VRRM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
60)). Resideo Technologies, Inc. (REZI) carries a higher beta of 2. 27 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VRRM: +46. 3%, REZI: +38. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VRRM and PRSO and CWAN and REZI and OSIS?
These companies operate in different sectors (VRRM (Technology) and PRSO (Technology) and CWAN (Technology) and REZI (Industrials) and OSIS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: VRRM is a small-cap deep-value stock; PRSO is a small-cap quality compounder stock; CWAN is a small-cap high-growth stock; REZI is a small-cap quality compounder stock; OSIS is a small-cap quality compounder stock. REZI pays a dividend while VRRM, PRSO, CWAN, OSIS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.